Tirzepatide 10mg

Tirzepatide 10mg research peptide UK supplied with independent COA tested by Janoshik. Buy Tirzepatide 10mg UK in sterile vials. This high-purity lyophilized peptide (99%+) is manufactured to the highest standards and supplied for qualified research use only. Each pack contains 10 vials, ensuring consistency for laboratory applications.

Tirzepatide is a novel dual agonist that targets both the GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors. Research interest has grown rapidly because of its combined action on glucose regulation, appetite control, and weight management. In preclinical and clinical research environments, Tirzepatide has been studied for its ability to reduce fasting glucose levels, improve insulin sensitivity, and promote body weight reduction. Researchers are particularly interested in its potential applications for metabolic health, obesity research, and type 2 diabetes pathways.

Because of its dual receptor mechanism, Tirzepatide is considered a next-generation incretin mimetic. Its unique structure and activity profile provide researchers with a valuable tool for investigating advanced therapeutic pathways that go beyond traditional GLP-1 analogues. Batch-verified COA testing ensures reliability and consistency, while UK-based supply guarantees fast dispatch and secure packaging.

Storage: Store lyophilized vials at –20°C. After reconstitution, keep between 2–8°C. Handle with sterile technique. COA included with every batch.

Key details:
– Product: Tirzepatide 10mg research peptide UK
– Pack size: 10 vials
– Verified by Janoshik, Batch Unknown
– Independent COA provided

For research use only – not for human consumption. UK-only supply. 18+ restriction applies.